Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
暂无分享,去创建一个
Caetano Souto-Maior | Jessica G King | Ricardo Aguas | M Gabriela M Gomes | M. Gomes | R. Águas | K. Langwig | C. Penha-Gonçalves | Marcelo U Ferreira | R. M. Corder | M. U. Ferreira | G. Gonçalves | Rodrigo M Corder | Kate E Langwig | Jorge Carneiro | Guilherme Goncalves | Carlos Penha-Goncalves | C. Souto-Maior | Jessica G. King | J. Carneiro | Kate E. Langwig | Marcelo U. Ferreira | Marcelo U. Ferreira | Jorge Carneiro | M. G. M. Gomes | Kate e. Langwig | Marcelo U Ferreira | M. Gomes | Jessica G. King | Marcelo U. Ferreira
[1] Joel Hellewell,et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[2] P. E. Kopp,et al. Superspreading and the effect of individual variation on disease emergence , 2005, Nature.
[3] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[4] Claire Donnat,et al. Modeling the heterogeneity in COVID-19's reproductive number and its impact on predictive scenarios , 2020, Journal of Applied Statistics.
[5] Mark Jit,et al. Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..
[6] Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: A case study in the Amazon Basin , 2020, PLoS computational biology.
[7] Ruiyun Li,et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.
[8] Benjamin J Cowling,et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong , 2020, Nature Medicine.
[9] Jan Hasenauer,et al. PESTO: Parameter EStimation TOolbox , 2017, Bioinform..
[10] G. Leung,et al. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.
[11] A. Heidarzadeh,et al. Seroprevalence of COVID-19 virus infection in Guilan province, Iran , 2020, medRxiv.
[12] Aravind Srinivasan,et al. Modelling disease outbreaks in realistic urban social networks , 2004, Nature.
[13] Hannah Fry,et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[14] Yiu Chung Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[15] M. Gabriela M. Gomes,et al. Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: A case study in the Amazon Basin , 2019, bioRxiv.
[16] Ruifu Yang,et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China , 2020, Science.
[17] Ken Eames,et al. "Herd immunity": a rough guide. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] V. Colizza,et al. Expected impact of lockdown in Île-de-France and possible exit strategies , 2020, medRxiv.
[19] P. Klepac,et al. Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project , 2020, medRxiv.
[20] G. Chowell,et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[21] R. Mikolajczyk,et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.
[22] C. Dolea,et al. World Health Organization , 1949, International Organization.
[23] Shweta Bansal,et al. Network frailty and the geometry of herd immunity , 2006, Proceedings of the Royal Society B: Biological Sciences.
[24] A. Vespignani,et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.
[25] P. Klenerman,et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) , 2021, The Lancet.
[26] B. Horta,et al. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil , 2020, Nature Medicine.
[27] M. Gomes,et al. Introducing risk inequality metrics in tuberculosis policy development , 2018, Nature Communications.
[28] Introducing risk inequality metrics in tuberculosis policy development , 2018 .
[29] Sebastian Funk,et al. Extended data: Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China , 2020 .
[30] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[31] Yonatan H. Grad,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[32] Anne Kimball,et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.
[33] J. Lessler,et al. Estimating the burden of SARS-CoV-2 in France , 2020, Science.
[34] A. Vespignani,et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China , 2020, Science.
[35] Carl A. B. Pearson,et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.
[36] M. Lipsitch,et al. A Missing Dimension in Measures of Vaccination Impacts , 2014, PLoS pathogens.
[37] M. Lipsitch,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[38] J. Tang,et al. Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries , 2020, Journal of Infection.
[39] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[40] Quentin J. Leclerc,et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.
[41] W. Pegden,et al. Frailty variation models for susceptibility and exposure to SARS-CoV-2 , 2021, medRxiv.
[42] Frank Ball,et al. The disease-induced herd immunity level for Covid-19 is substantially lower than the classical herd immunity level , 2020, medRxiv.
[43] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[44] N. Linton,et al. Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.
[45] Quentin J. Leclerc,et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.
[46] Frank Ball,et al. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2 , 2020, Science.
[47] G. Gonçalves. Herd immunity: recent uses in vaccine assessment , 2008, Expert review of vaccines.
[48] W. Wei,et al. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[49] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[50] J. Dushoff,et al. The entomological inoculation rate and Plasmodium falciparum infection in African children , 2005, Nature.